Loading...
BVMF
AALR3
Market cap162mUSD
May 30, Last price  
6.09BRL
1D
1.50%
1Q
-47.50%
Jan 2017
-58.43%
IPO
-66.28%
Name

Centro de Imagem Diagnosticos SA

Chart & Performance

D1W1MN
P/E
—
P/S
0.76
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.15%
Rev. gr., 5y
2.55%
Revenues
1.22b
+3.17%
184,186,000275,898,000393,149,000699,664,000951,470,0001,077,876,0001,076,918,0001,072,865,000928,787,0001,136,572,0001,085,009,0001,179,584,0001,216,992,000
Net income
-129m
L-43.34%
28,510,00027,679,000-4,165,000-12,767,00014,792,0006,652,00040,087,00041,300,000-92,430,0001,988,000-219,243,000-227,878,000-129,119,000
CFO
-41m
L
39,074,00017,113,00047,694,00098,556,00078,974,000134,194,000161,189,000213,410,000117,864,000149,128,000187,303,000102,304,000-41,021,000
Dividend
Apr 28, 20200.087297 BRL/sh
Earnings
Aug 06, 2025

Profile

Centro de Imagem Diagnósticos S.A. provides diagnostic medicine services in Brazil. Its diagnostic medicine services include imaging diagnosis and chart-based diagnosis; nuclear medicine and cytology; pathological anatomy; and clinical tests. The company also engages in the provision of health consulting, advisory, courses and lectures, and the services related to health; management of chronic diseases; scientific and technologic research and development related to diagnostic medicine; preparation, issue, publication, and distribution of newspapers, books, magazines, periodicals, and other media for the dissemination of scientific knowledge; and grant and management of business franchises. Centro de Imagem Diagnósticos S.A. was founded in 1992 and is headquartered in São Paulo, Brazil.
URL
https://centrodaimagem.com.br/
IPO date
Oct 28, 2016
Employees
Domiciled in
BR
Incorporated in
BR

Valuation

Title
BRL in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,216,992
3.17%
1,179,584
8.72%
1,085,009
-4.54%
Cost of revenue
1,109,932
1,139,859
1,097,675
Unusual Expense (Income)
NOPBT
107,060
39,725
(12,666)
NOPBT Margin
8.80%
3.37%
Operating Taxes
15,752
19,090
(13,991)
Tax Rate
14.71%
48.06%
NOPAT
91,308
20,635
1,325
Net income
(129,119)
-43.34%
(227,878)
3.94%
(219,243)
-11,128.32%
Dividends
(1,884)
Dividend yield
0.07%
Proceeds from repurchase of equity
310,900
185,080
(3,907)
BB yield
-30.57%
-15.04%
0.15%
Debt
Debt current
306,858
407,035
424,490
Long-term debt
873,553
1,166,169
1,178,781
Deferred revenue
Other long-term liabilities
435,754
81,296
78,200
Net debt
1,031,044
1,346,952
1,375,643
Cash flow
Cash from operating activities
(41,021)
102,304
187,303
CAPEX
(99,387)
(91,520)
(113,009)
Cash from investing activities
142,409
(111,150)
(142,496)
Cash from financing activities
(205,011)
8,697
196,846
FCF
(194,485)
(26,670)
110,614
Balance
Cash
145,696
218,595
220,431
Long term investments
3,671
7,657
7,197
Excess cash
88,517
167,273
173,378
Stockholders' equity
19,462
946,272
987,365
Invested Capital
2,504,171
2,167,258
2,188,177
ROIC
3.91%
0.95%
0.06%
ROCE
4.23%
1.70%
EV
Common stock shares outstanding
118,933
118,293
117,815
Price
8.55
-17.79%
10.40
-51.85%
21.60
44.29%
Market cap
1,016,876
-17.34%
1,230,247
-51.66%
2,544,804
44.62%
EV
2,089,944
2,603,735
3,952,668
EBITDA
209,291
132,855
105,071
EV/EBITDA
9.99
19.60
37.62
Interest
177,885
246,997
151,483
Interest/NOPBT
166.15%
621.77%